The de novo selection of drug-resistant malaria parasites

Proceedings of the Royal Society B: Biological Sciences

Volumn 270, Issue 1514, 2003, Pages 545-554

  White, N J ^a,b   Pongtavornpinyo, W ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Antimalarials; Malaria; Plasmodium falciparum; Resistance

Indexed keywords

ARTEMISININ;

DRUG RESISTANCE; MALARIA;

ANTIBIOTIC RESISTANCE; BIOMASS; CONFERENCE PAPER; DISEASE TRANSMISSION; LIFE CYCLE; MALARIA; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; PROPHYLAXIS; RISK;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0037423830     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2002.2241     Document Type: Conference Paper

References (49)

1. Austin, D. J. & Anderson, R. M. 1999 Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Phil. Trans. R. Soc. B 354, 721-738. (DOI 10.1098/rstb.1999.0425.)
2. Bloland, P. B., Ettling, M. & Meek, S. 2000 Combination therapy for malaria in Africa: hype and hope. Bull. WHO 78, 1378-1388.
3. Bonhoeffer, S., Lipsitch, M. & Levin, B. R. 1997 Evaluating treatment protocols to prevent antibiotic resistance. Proc. Natl Acad. Sci. USA 94, 12 106-12 111.
4. Brockman, A., Price, R. N., Van Vugt, M., Heppner, D. G., Walsh, D., Sookto, P., Wimonwattrawatee, T., Looareesuwan, S., White, N. J. & Nosten, F. 2000 Plasmodium falciparum antimalarial drug susceptibility on the northwestern border of Thailand during five years of extensive artesunate-mefloquine use. Trans. R. Soc. Trop. Med. Hyg. 94, 537-544.
5. Burgess, R. W. & Young, M. D. 1959 The development of pyrimethamine resistance by Plasmodium falciparum. Bull. WHO 20, 37-46.
6. Chawira, A. N., Warhurst, D. C., Robinson, B. L. & Peters, W. 1987 The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans. R. Soc. Trop. Med. Hyg. 81, 554-558.
7. Cowman, A. F., Galatis, D. & Thompson, J. K. 1994 Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl Acad. Sci. USA 91, 1143-1147.
8. Curtis, C. F. & Otoo, L. N. 1986 A simple model of the buildup of resistance to mixtures of antimalarial drugs. Trans. R. Soc. Trop. Med. Hyg. 80, 889-892.
9. Day, N. P. J. (and 11 others) 1996 Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. Blood 88, 4696-4700.
10. Dye, C. & Williams, B. G. 1997 Multigenic drug resistance among inbred malaria parasites. Proc. R. Soc. Lond. B 264, 61-67. (DOI 10.1098/rspb.1997.0009.)
11. Fairley, N. H. 1947 Sidelights on malaria in man obtained by subinoculation experiments. Trans. R. Soc. Trop. Med. Hyg. 40, 521-576.
12. Field, J. W. 1949 Blood examination and prognosis in acute falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 43, 33-68.
13. Hastings, I. M. & D'Alessandro, U. 2000 Modelling a predictable disaster: the rise and spread of drug-resistant malaria. Parasitol. Today 16, 340-347.
14. Hastings, I. M., Watkins, W. M. & White, N. J. 2002 Pharmacokinetic parameters affecting the evolution of drug-resistance in malaria: the role of the terminal elimination half-life. Phil. Trans. R. Soc. Lond. B357, 505-519. (DOI 10.1098/rstb.2001.1036.)
15. James, S. P., Nichol, W. D. & Shute, P. G. 1932 A study of induced malignant tertian malaria. Proc. R. Soc. Med. 25, 1153-1186.
16. Jeffery, G. M. & Eyles, D. E. 1955 Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Am. J. Trop. Med. Hyg. 4, 781-789.
17. Kitchen, S. F. 1949 Symptomatology: general considerations and falciparum malaria. In Malariology, vol. 2 (ed. M. F. Boyd), pp. 996-1017. Philadelphia, PA: W. B. Saunders.
18. Korsinczky, M., Chen, N., Kotecka, B., Saul, A., Rieckmann, K. & Cheng, Q. 2000 Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob. Agents Chemother. 44, 2100-2108.
19. Lipsitch, M. & Levin, B. R. 1997 The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41, 363-373.
20. Looareesuwan, S., Viravan, C., Webster, H. K., Kyle, D. E., Hutchinson, D. B. & Canfield, C. J. 1996 Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 54, 62-66.
21. Marsh, K. 1998 Malaria disaster in Africa. Lancet 352, 924-925.
22. Martin, D. C. & Arnold, J. D. 1968 The effect of parasite populations on the curative action of pyrimethamine. Trans. R. Soc. Trop. Med. Hyg. 62, 379-384.
23. Nosten, F., ter Kuile, F., Chongsuphajaisiddhi, T., Luxemburger, C., Webster, H. K., Edstein, M., Phaipun, L., Thew, K. L. & White, N. J. 1991 Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337, 1140-1143.
24. Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S. & White, N. J. 2000 Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356, 297-302.
25. Nzila, A. M., Nduati, E., Mberu, E. K., Hopkins Sibley, C., Monks, S. A., Winstanley, P. A. & Watkins, W. M. 2000 Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulphadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. J. Infect. Dis. 181, 2023-2028.
26. Paget-McNicol, S. & Saul, A. 2001 Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum. Parasitology 122, 497-505.
27. Peters, W. 1969 Drug resistance: a perspective. Trans. R. Soc. Trap. Med. Hyg. 63, 25-45.
28. Peters, W. 1987 Chemotherapy and drug resistance in malaria, 2nd edn. London: Academic.
29. Peters, W. 1990 The prevention of antimalarial drug resistance. Pharmacal. Theor. 47, 499-508.
30. Ponnudurai, T., Lensen, A. H. W., Van-Gemert, G. J. A., Bolmer, M. G. & Meuwissen, J. H. E. 1991 Feeding behaviour and sporozoite ejection by infected Anopheles stephensi. Trans. R. Soc. Trop. Med. Hyg. 85, 175-180.
31. Price, R. N., Luxemburger, C., Van Vugt, M., Nosten, F., Kham, A., Simpson, J., Looareesuwan, S., Chongsuphajaisiddhi, T. & White, N. J. 1998 Artesunate and mefloquine in the treatment of uncomplicated multi-drug resistant hyperparasitaemic falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 92, 207-211.
32. Price, R. N., Nosten, F., Luxemburger, C., Phaipun, L., ter Kuile, F., Van Vugt, M., Chongsuphajaisiddhi, T. & White, N. J. 1999 Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 60, 1019-1023.
33. Rathod, P. K., McErlean, T. & Lee, P. C. 1997 Variations in frequencies of drug resistance in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 94, 9389-9393.
34. Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K. & Cowman, A. F. 2000 Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403, 906-909.
35. Rosenburg, R. & Wirtz, R. A. 1990 An estimation of the number of sporozoites ejected by a feeding mosquito. Trans. R. Sac. Trap. Med. Hyg. 84, 209-212.
36. Simpson, J. A., Watkins, E. R., Price, R. N., Aarons, L., Kyle, D. E. & White, N. J. 2000 Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance. Andmicrob. Agents Chemother. 44, 3414-3424.
37. Simpson, J. A., Aarons, L., Collins, W. E., Jeffery, G. & White, N. J. 2002 Population dynamics of the Plasmodium falciparum parasite within the adult human host in the absence of antimalariall drugs. Parasitology 124, 247-263.
38. Smith, T., Schellenberg, J. A. & Hayes, R. 1994 Attributable fraction estimates and case definitions for malaria in endemic areas. Stat. Med. 13, 2345-2358.
39. Snow, R. W., Craig, M. H., Deichmann, U. & Marsh, K. 1999 Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull. WHO 77, 624-640.
40. Su, X., Kirkman, L. A., Fujioka, H. & Wellems, T. E. 1997 Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91, 593-603.
41. ter Kuile, F. O., Luxemburger, C., Nosten, F., Phaipun, L., Chongsuphajaisiddhi, T. & White, N. J. 1995 Predictors of mefloquine treatment failure: a prospective study in 1590 patients with uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 89, 660-664.
42. Trape, J. F., Pison, G., Preziosi, M. P., Enel, C., de Lou, A. D., Delaunay, V., Samb, B., Lagarde, E., Molez, J. F. & Simondon, F. 1998 Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. Paris Série III 321, 689-697.
43. Watkins, W. M. & Mosobo, M. 1993 Treatment of Plasmodium falciparum malaria with pyrimethamine-sulphadoxine: selective pressure for resistance is a function of long elimination half-life. Trans. R. Soc. Trop. Med. Hyg. 87, 75-78.
44. Watkins, W. M., Mberu, E. K., Winstanley, P. A. & Plowe, C. V. 1999 More on the efficacy of antifolate antimalarial combinations in Africa. Parasitol. Today 15, 131-132.
45. White, N. J. 1992 Antimalarial pharmacokinetics and treatment regimens. Br. J. Clin. Pharmacol. 34, 1-10.
46. White, N. J. 1997 Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41, 1413-1422.
47. White, N. J. 1999a Antimalarial drug resistance and mortality in falciparum malaria. Trop. Med. Int. Hlth 4, 469-470.
48. White, N. J. 1999b Antimalarial drug resistance and combination chemotherapy. Phil. Trans. R. Soc. Lond. B 354, 739-749. (DOI 10.1098/rstb.1999.0426.)
49. White, N. J., Van Vugt, M. & Ezzet, F. 1999 Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin. Pharmacokinet. 37, 105-125.